The role of lymphadenectomy in esophageal cancer

Rays - International Journal of Radiological Sciences

Volumn 30, Issue 4, 2005, Pages 323-327

  Carleo, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Esophageal cancer; Lymph node dissection; Micrometastasis; Skip metastasis

Indexed keywords

CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MICROMETASTASIS; POSTOPERATIVE CARE; REVIEW; SENTINEL LYMPH NODE; SURGEON;

ESOPHAGEAL NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS;

EID: 33745314462     PISSN: 03907740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. th edn. Philadelphia: Saunders, 1996, 3-38.
2. HAGIWARA A, TAKAHASHI T, KOJIMA O, et al. Endoscopic local injection of a new drug-delivery format of Peplomycin for superficial esophageal cancer: a pilot study. Gastroenterology 1993; 104: 1037-1043.
3. AKIYAMA H, TSURUMARU M, KAWAMURA T, ONO Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg 1981; 194: 438-446.
4. VAN DE VEN C, DE LEYN P, COOSEMANS W, et al. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg 1999; 15: 769-773.
5. HOSCH SB, STOECKLEIN NH, PICHLMEIER U, et al. Esophageal cancer. The mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 2001; 19: 1970-1975.
6. MARTINI N, FLEHINGER BJ, ZAMAN MB, et al. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983; 198: 386-397.
7. CASSON AG, RUSCH VW, GINSBERG RJ, et al. Lymph node mapping of esophageal cancer. Ann Thorac Surg 1994; 58: 1569-1570.
8. JAPANESE SOCIETY FOR ESOPHAGEAL DISEASES. Guide lines for clinical and pathological studies on carcinoma of the esophagus. Jap J Surg 1976; 6: 69-78.
9. BUMM R, WONG J. More or less surgery for esophageal cancer: extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma: how much is necessary? Dis Esoph 1994; 7: 151-155.
10. D. LIEBERMANN-MEFFERT. Anatomical basis for the approach and extent of surgical treatment of esophageal cancer. Dis Esoph 2001; 14: 81-84.
11. ORRINGER MB. Editiorial comment on occult cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg 1997; 113: 538-539.
12. AKIYAMA H, TSURUMARU M, UDAGAWA H, et al. Systemic lymph node dissection for esophageal cancer: effective or not? Dis Esoph 1994; 7: 2-13.
13. HULSCHER JB, VAN SANDICK JW, DE BOER AGEM, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-1669.
14. SIEWERT JR, RODER JD. Lymphadenectomy in esophageal cancer surgery. Dig Surg 1993; 10: 135-140.
15. SKINNER DB. En bloc resection for neoplasms of the esophagus and cardia. J Thoracic Cardiovasc Surg 1983; 83: 59-67.
16. LERUT T, COOSEMANS W, DECKER G, et al. Extended surgery for cancer of the esophagus and gastroesophageal junction. J Surg Res 2004; 117: 58-63.
17. KATO H, WATANANBE H, TACHIMORI Y, IIZUKA T. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991; 51: 931-935.
18. NISHIHIRA T, HIRAYAMA K, MORI S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998; 175: 47-51.
19. ISONO K, OCHIAI T, KOIDE Y. Indications for extended three-field lymphadenectomy for esophageal cancer. Dis Esophagus 1994, 7: 147-150.
20. FUJITA H, KAKEGAWA T, YAMANA H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer: comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222: 654-662.
21. LERUT T, NAFTEUX P, MOONS J, COOSEMANS W, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome. Ann Surg 2004; 240: 962-974.
22. IZBICKI JR, HOSCH SB, PICHLMEIER U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337: 1188-1194.
23. NATSUGOE S, MUELIER J, STEIN HJ, et al. Micrometastases and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer 1998; 83: 858-866.
24. KOMUKAI S, NISHIMAKI T, SUZUKI T, et al. Significance of immunohistochemical nodal micrometastasis prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg 2002; 89: 213-219.
25. THOMAS P, DODDOLI C, LIENNE P, et al. Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg 1997; 84: 119-125.